四环医药：预计2025年净利润不低于1.5亿元 医美业务实现收入逾14亿元

Group 1 - The company expects to achieve revenue of no less than RMB 2.5 billion in the fiscal year 2025, representing a growth rate of over 30% compared to the same period last year [1] - The company anticipates a net profit of no less than RMB 150 million for the fiscal year 2025 [1] - The medical beauty business is projected to generate over RMB 1.4 billion in revenue and over RMB 700 million in segment profit for the fiscal year 2025, with both revenue and segment profit growth rates exceeding 90% compared to the previous year [1]